Digest Network How does it work
Network
/
Society
Ge
Not verified

Genethon

What we write about

BiotechnologyHealthMedicine - variousPharmaceuticalsScienza

16 Press releases

View all press releases
11/03/2026
Eventi
Health
Scienza
Pharmaceuticals
Medicine - various
Gene Therapy for Duchenne Muscular Dystrophy: Genethon Confirms Two-Year Efficacy in Patients Treated with Its Drug Candidate GNT0004 at Therapeutic Dose in the First Phase of Its Clinical Trial
Source
Genethon
Issuer
Business Wire
1.00
0
26/01/2026
Scienza
Children
Biotechnology
Medicine - various
Health
Windows / Shopping
Pharmaceuticals
Labour market
Industria
Genethon Advances Groundbreaking Gene Therapies for Patients with Rare Genetic Diseases
Source
Genethon
Issuer
Business Wire
1.00
0
14/01/2026
Volunteer / Solidarity / Non-Profit
Labour market
Scienza
Biotechnology
Pharmaceuticals
Sanità
Health
Medicine - various
Genethon Signs Licensing Agreement With AskBio for the Development of an Investigational Gene Therapy for Pompe Disease
Source
Genethon
Issuer
Business Wire
1.00
0
06/01/2026
Eventi
WEB AND SOCIAL NETWORK
Scienza
Biotechnology
Pharmaceuticals
Sanità
Health
Medicine - various
Genethon Management to Host Partnering Meetings During JP Morgan Healthcare Week, January 12 -16, 2026 in San Francisco, CA
Source
Genethon
Issuer
Business Wire
1.00
0
10/10/2025
Multimedia
Scienza
Biotechnology
Pharmaceuticals
Sanità
Health
Medicine - various
Eventi
Fairs
Industria
Data from GNT-018-IDES Trial Supports Feasibility of imlifidase as Pretreatment in Gene Therapy Treatment for Patients With Crigler–Najjar Syndrome Who Are Immune to AAV
Source
Genethon
Issuer
Business Wire
1.00
0
09/10/2025
Scienza
Biotechnology
Pharmaceuticals
Sanità
Health
Medicine - various
WEB AND SOCIAL NETWORK
Volunteer / Solidarity / Non-Profit
Eventi
Industria
Genethon Confirms 2-Year Efficacy in Duchenne Muscular Dystrophy Patients Treated With Its Low Dose Micro-Dystrophin Gene Therapy (GNT0004) at the ESGCT 32nd Annual Congress
Source
Genethon
Issuer
Business Wire
1.00
0
28/07/2025
Industria
Biotechnology
Health
Pharmaceuticals
Medicine - various
Genethon to Launch Pivotal Trial in Europe of GNT0004 a Low-Dose Microdystrophin Gene Therapy for Duchenne Muscular Dystrophy
Source
Genethon
Issuer
Business Wire
1.00
0
19/06/2025
Biotechnology
Health
Pharmaceuticals
Medicine - various
Eventi
Clinical Milestones, Vector Innovation Key to Gene Therapy, GenoTher Biocluster’s First International Summit, Atamyo Therapeutics’ Progress for LGMDs Highlight Genethon’s Most Recent Newsletter
Source
Genethon
Issuer
Business Wire
1.00
0
19/05/2025
Eventi
Biotechnology
Health
Pharmaceuticals
Medicine - various
Genethon Presents Two Year Consolidated Results of Its Gene Therapy Trial for Duchenne Muscular Dystrophy: Maintenance of Motor Functions and Significant, Sustained Reduction in CPK Levels in Patients Treated at the Effective Dose at ASGCT 2025
Source
Genethon
Issuer
Business Wire
1.00
0
27/02/2025
Health
HIV, AIDS and autoimmune disorders
Biotechnology
Medicine - various
Pharmaceuticals
Industria
Genethon Celebrates Rare Disease Day by Highlighting New Technologies to Advance Gene Therapies and Bring Hope to Millions of Patients Worldwide
Source
Genethon
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0